We've always represented West Virginians statewide. Our new Charleston office gives Kanawha County and surrounding communities a more convenient place to meet our team.
If your infant developed necrotizing enterocolitis after consuming certain baby formulas, you may be affected by ongoing mass tort litigation. Families in Keyser and across West Virginia are seeking answers and compensation after serious medical complications required hospitalization, surgery, or long-term care. Our firm provides clear information about the claims process, common issues in these cases, and next steps to preserve evidence and protect legal rights. We can review medical records, formula purchase and recall information, and the timeline of your child’s illness to determine whether a claim may be viable and how best to proceed on behalf of your family.
Pursuing a NEC formula claim can provide financial support for medical bills, rehabilitation, ongoing care, and related expenses, while also creating a public record that may encourage product safety improvements. For families in Keyser and beyond, a successful claim can reduce the long-term economic burden of infant injuries and help cover specialized therapies, adaptive equipment, and follow-up care. Beyond compensation, participating in coordinated litigation gives families a stronger voice when complex manufacturing, supply chain, or labeling issues contributed to an infant’s illness. Understanding the potential benefits and likely timelines helps families make informed decisions about participating in a mass tort or related legal action.
Necrotizing enterocolitis is a medical condition in which portions of an infant’s intestine become inflamed and can begin to deteriorate, sometimes leading to infection, perforation, and the need for surgical removal of damaged bowel. It most commonly affects premature or low birthweight infants and can present with feeding intolerance, abdominal swelling, or changes in stool. Treatment ranges from supportive care and antibiotics to surgery in severe cases. When NEC appears after formula feeding, clinicians and investigators consider whether contamination, formulation, or preparation practices may have contributed to the infant’s condition.
A mass tort is a legal process used when many individuals suffer similar harm from the same product, drug, or event and pursue coordinated claims against common defendants. Unlike a class action, mass torts treat each claimant’s injuries, damages, and facts individually, while consolidating certain pretrial processes for efficiency. This approach allows families to pursue individualized compensation based on the particular medical outcomes and financial impact they experienced. Mass tort coordination helps manage complex discovery, scientific evidence, and multi-jurisdictional issues while still preserving each claimant’s unique case for resolution.
A class action consolidates many claimants into a single lawsuit when common legal or factual issues predominate and individual differences are less important for relief. In this structure, one or more plaintiffs represent the interests of the entire group, and any settlement typically applies to class members under court supervision. Class actions can be efficient when damages are similar and individualized proof is not required, but they may limit each person’s ability to seek tailored compensation. For NEC-related formula claims, the choice between class action and mass tort depends on the nature of the evidence and how injuries vary among infants.
Compensatory damages are intended to make an injured person and their family whole by covering measurable losses tied to the injury, such as medical bills, rehabilitation, lost earning capacity of caregivers, and costs for long-term care. In infant injury cases, compensatory damages can include past and future medical expenses, therapies, assistive equipment, and household modifications. Non-economic losses like pain, suffering, and loss of enjoyment of life may also be part of compensatory awards. Documenting medical costs, projected future needs, and the daily impact on family life is important to present a full picture of damages.
Request complete hospital and clinic records as soon as possible to preserve critical evidence about diagnosis, treatment, and outcomes. Copies of neonatal intensive care unit notes, surgical reports, medication logs, and discharge summaries form the backbone of any medical-related claim and help establish the timing and severity of the infant’s condition. Early collection of these documents also enables timely review by medical reviewers who can identify gaps in care or links to product exposure, and it prevents potential loss or destruction of records as healthcare systems manage large caseloads and routine record retention schedules.
Keep any remaining formula containers, lids, batch or lot numbers, and retailer receipts in a safe, dry place to maintain a chain of custody for physical evidence. Photographs of packaging, labels, and lot numbers can be helpful if the original container is disposed of during an emergency, and maintaining records of where and when the product was purchased helps trace supply chain issues. Collect any correspondence regarding product recalls or notices from retailers, as well as bank or credit card statements that show purchase dates, to support efforts to link a specific product batch to your child’s illness.
Keep a detailed timeline of symptoms, medical visits, medications administered, and any changes in feeding or care routines to clarify the sequence of events surrounding the infant’s illness. Note dates and times of emergency room visits, specialist consultations, diagnostic imaging, and surgical interventions, as well as any instructions provided by clinicians and responses to treatment. This contemporaneous documentation, combined with the medical record, supports a clear narrative about exposure, onset, and clinical progression, which is important for both medical review and legal evaluation of a potential claim.
A comprehensive approach is often appropriate when there is evidence that a single product or batch harmed many infants across different hospitals or regions, suggesting systemic issues in manufacturing or distribution. Coordinated litigation allows claimants to share the expense of pursuing complex scientific and forensic testing while centralizing discovery related to manufacturing processes, quality control, and complaint histories. Centralization also promotes consistent rulings on key legal issues and can make it easier for families to access medical and economic experts needed to quantify damages over an infant’s lifetime.
When causation involves microbiology, contamination testing, or nuanced neonatal care questions, a broad legal strategy that consolidates resources can help secure the specialized medical analysis needed to link a product to injury. Centralized cases better withstand defendants’ challenges and allow for pooled expert review of laboratory and clinical data, which may be costly for individual families to obtain separately. Coordinated litigation also streamlines communication and gives families a clearer picture of the overall progress of investigations, while preserving each claimant’s right to pursue individualized damages based on their specific medical trajectory.
A more limited, individual approach may be appropriate when an infant’s medical records show a clear and direct link to a single event or product exposure with strong supporting documentation, and when the incident appears isolated rather than part of a broader pattern. In those situations, focused litigation can proceed without the need for large consolidated discovery, and claims may resolve more quickly if liability is straightforward. Families should still collect comprehensive medical documentation and product evidence to support their case and consult with counsel about whether an individual filing or participation in coordinated actions is the best course.
If test results, product lot tracing, and clinical findings directly tie a single infant’s injury to a particular formula batch, an individual lawsuit can efficiently seek compensation without the extended timelines of mass litigation. When the evidence is compelling and the damages are clearly documented, focused cases may settle or proceed to trial on a shorter timetable. Consultation with counsel early on will identify whether the strength of the individual proof makes a standalone claim sensible, while still preserving the option to coordinate with other families if broader links emerge during investigation.
Premature and low birthweight infants are more vulnerable to NEC and often require special feeding and monitoring, which can increase the risk of severe outcomes if a formula is contaminated or improperly formulated. These infants may need prolonged NICU stays, specialized nutritional plans, and ongoing therapies, and when NEC occurs in that context families should carefully document those medical details for any claim.
When manufacturers issue recalls or public health agencies identify contamination, families who used affected lots should preserve packaging and purchase records and seek prompt medical assessment for any symptoms consistent with NEC. Recall information and lot tracing can be core evidence linking a particular batch to an infant’s illness and support coordinated legal action.
Errors in storage, reconstitution, or hospital supply handling can introduce risks that contribute to NEC, and investigating hospital procedures alongside product distribution records may reveal contributing factors. Families should request facility protocols and any incident reports related to feeding practices or product handling to determine whether those issues played a role in an infant’s condition.
Stephen New & Associates provides focused attention to families facing serious infant injuries from formula-related NEC, offering practical guidance about evidence preservation, medical documentation, and the litigation timeline. The firm represents clients throughout West Virginia, including Keyser and Mineral County, combining local knowledge with familiarity in handling complex product and medical injury matters. Our goal is to provide clear communication, aggressive case preparation, and strategic evaluation of whether coordinated mass tort participation or an individual filing best serves your child’s needs and your family’s goals for recovery and accountability.
Necrotizing enterocolitis, commonly called NEC, is a serious intestinal condition that primarily affects newborns and can involve inflammation, infection, and tissue death of portions of the bowel. Symptoms often include feeding intolerance, abdominal distention, bloody stools, and systemic signs of infection, and severe cases may require surgery and long hospital stays. When NEC arises after formula feeding, investigators consider whether contamination, improper formulation, or preparation issues could have contributed. Medical records, laboratory results, and feeding histories are reviewed to determine the likely cause and whether a product played a role. Establishing a link between formula and NEC depends on detailed clinical timelines, evidence of exposure to a particular product or lot, and sometimes laboratory testing that ties contaminants to the infant’s illness. Investigations may include tracing purchase records, identifying lot and batch numbers on packaging, reviewing recall notices, and consulting medical and scientific literature. Families should promptly preserve packaging and records, obtain full hospital documentation, and seek legal review to determine whether the facts suggest a claim against a manufacturer, distributor, or another party involved in the supply chain.
Determining whether your child’s NEC is linked to formula begins with a careful review of medical records, feeding logs, and any remaining packaging or receipts that identify the product used. Important information includes the timing of symptoms relative to formula exposure, whether multiple infants experienced similar issues from the same product batch, and any laboratory findings indicating contamination or pathogens. Copies of NICU notes, imaging and surgical reports, and communications about recalls or product concerns all help build the factual picture needed for evaluation. Because causation often involves medical, microbiological, and manufacturing considerations, attorneys who handle these matters work with clinicians and technical reviewers to assess whether a particular lot or production process could be implicated. If your family preserved formula containers, lot numbers, or proof of purchase, those items can be critical. Even if packaging is no longer available, detailed medical documentation and retailer records may still support tracing and linking a product to an infant’s NEC for legal purposes.
Compensation in NEC related claims can include reimbursement for past and future medical expenses such as hospital bills, surgical procedures, medications, therapies, and durable medical equipment needed for ongoing care. Families may also recover compensation for the time caregivers lose from work, travel to medical appointments, and out-of-pocket costs related to specialized care plans. Documenting treatment schedules, therapy needs, and projected future medical needs helps calculate the economic impact and establish the financial demands a child will face over their lifetime. Non-economic damages can also be pursued to address the pain and suffering endured by the infant and family, as well as the emotional and lifestyle changes that result from a serious childhood injury. In some cases punitive damages may be available if conduct by a manufacturer or distributor was particularly harmful, but availability depends on the facts and legal theories in the jurisdiction. A thorough evaluation of medical records and expert projections helps families understand potential recovery and make informed decisions about pursuing a claim.
Statutes of limitation vary by state and by the legal theory underlying a claim, and it is important for families in West Virginia to act in a timely manner to preserve their rights. In many jurisdictions, the clock for filing a personal injury lawsuit starts when the injury is discovered or should have been discovered, but neonatal cases and injuries that manifest over time may involve different tolling rules. Because these deadlines can be complex and subject to exceptions, early consultation with counsel ensures that critical dates are identified and necessary steps are taken to avoid losing legal rights. Even if you are unsure whether a claim exists, preserving evidence and initiating a legal review quickly helps protect options. Attorneys can request and preserve medical and product records, issue preservation notices to manufacturers or hospitals, and advise on whether immediate filings or protective steps are necessary. Acting promptly also facilitates investigation while records are intact and witnesses have fresh recollections of relevant events.
Choosing between joining a mass tort or filing an individual lawsuit depends on the nature of the evidence and the similarities among affected families. Mass tort coordination can be advantageous when many infants experienced similar injuries from the same product or lot, because it centralizes discovery, shares expert costs, and consolidates pretrial proceedings while preserving each family’s right to individual damages. Participating in a coordinated action can also increase efficiency in resolving common legal issues and exchanging critical evidence among claimants. An individual lawsuit may be more appropriate when an infant’s case is unique, when liability and damages are straightforward, or when a family seeks a faster resolution tailored to their specific needs. Counsel can evaluate the strength of individual medical evidence, the scope of any broader product issues, and the likely timeline to recommend whether coordinated litigation or an individualized approach better serves the family’s goals. Consultation helps clarify the tradeoffs and expected processes for each option.
Critical evidence in NEC formula cases includes complete hospital records, NICU notes, operative reports, imaging results, laboratory tests, and discharge summaries that document diagnosis, treatment, and outcomes. Feeding logs, nursing notes, and records that describe how formula was prepared or administered provide context about exposure, and pharmacy or medication records can show any concurrent therapies. Collecting purchase receipts, photographs of packaging, lot and batch numbers, and any recall notices helps connect a specific product to an infant’s illness and aids tracing through the supply chain for potential manufacturing or distribution issues. Other important materials include correspondence with healthcare providers, entries related to the infant’s developmental milestones, therapy plans for ongoing needs, and proof of caregiver time off work and related expenses. Statements from treating clinicians, when available, help explain the medical course and necessary future care. Legal teams often work with medical and technical reviewers to interpret records and reconstruct timelines that support causation and damages, so early evidence preservation and organized documentation significantly aid case development.
Responsibility in NEC cases may rest with manufacturers, packagers, distributors, retailers, or healthcare providers depending on the specific facts and the source of the problem. If contamination, formulation errors, or manufacturing defects are identified, manufacturers or suppliers can be named in claims. If a hospital’s storage, preparation, or administration procedures contributed to harm, facility liability may be examined as well. Determining responsible parties requires a careful review of production records, distribution chains, hospital protocols, and any investigation results that identify where a breakdown occurred. Legal claims may pursue multiple potential defendants simultaneously to ensure all possible sources of liability are addressed and to secure full recovery for affected families. Liability questions often involve technical and factual inquiry into how a product moved through the supply chain and how it was handled at each step. Counsel will coordinate investigative steps, including subpoenas for production of manufacturing and distribution records, to clarify responsibility and support claims against the appropriate parties.
Mass torts typically begin with a coordinated complaint or multiple related filings that centralize discovery and pretrial proceedings to efficiently resolve common factual and legal questions. Plaintiffs retain individualized claims for damages, while consolidated processes address shared issues such as product design, manufacturing practices, and scientific causation. The process may include identifying bellwether cases to provide representative outcomes, pursuing expert discovery, completing depositions, and engaging in settlement negotiations or trials depending on how the litigation progresses. Participation in a mass tort gives families access to coordinated investigation and pooled resources for expert review and testing, which can be particularly important in cases involving medical, microbiological, or manufacturing complexity. The timetable can be lengthy due to the need for technical discovery and testing, but mass torts can also lead to comprehensive resolutions that address many claimants’ needs through global settlements or structured recoveries, while maintaining each family’s right to pursue individualized remedies when appropriate.
If your child is still receiving medical care, it remains important to document ongoing treatments, medications, therapies, and follow-up visits to accurately capture past and future needs that a claim may address. Continue collecting medical bills, therapy notes, and provider projections about anticipated care, and keep a running record of how the condition affects daily life and family routines. Timely legal consultation helps preserve records, coordinate with medical professionals for necessary documentation, and assess whether interim financial assistance options are available to address immediate needs while litigation proceeds. Ongoing treatment does not prevent pursuing a claim; in fact, it often strengthens the record of lasting impact and projected future care. Counsel can work with medical professionals to estimate lifetime costs, recommend rehabilitation options, and include appropriate future medical and nonmedical support in damage calculations. Maintaining consistent communication with legal counsel ensures that newly available medical evidence is integrated into the case as treatment continues and prognosis evolves.
Many firms handle NEC and product-related injury claims on a contingency basis, which means families pay little or nothing upfront and legal fees are collected from proceeds only if there is a recovery. This arrangement reduces immediate financial barriers to pursuing claims, allows families to focus on medical care and recovery, and aligns legal incentives with achieving a successful outcome. Families should ask about fee structures, potential case expenses such as expert witness costs, and how those costs are handled so they have a clear understanding of potential financial responsibilities. Even with contingency arrangements, it is important to discuss how litigation costs are advanced, how expenses are deducted from recoveries, and whether any out-of-pocket payments might be required during litigation. Counsel can explain billing practices, expected timelines for major cost items like expert reports and testing, and strategies to manage expenses while pursuing compensation. Transparent communication about costs helps families plan and prevents surprises during the legal process.
Explore our complete legal services